Suppr超能文献

伴有远处转移的乳头状和滤泡状甲状腺癌的生存时间及“治愈”情况:密歇根大学治疗后的统计数据

Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy.

作者信息

Beierwaltes W H, Nishiyama R H, Thompson N W, Copp J E, Kubo A

出版信息

J Nucl Med. 1982 Jul;23(7):561-8.

PMID:7086528
Abstract

Between 1947 and 1980, 103 patients with well-differentiated thyroid carcinoma with metastases outside the neck were treated with sodium iodide (I-131) after surgical treatment. Forty-one patients had distant metastases first detected an average of 7.44 yr after the initial operation establishing the diagnosis of thyroid carcinoma. Follicular and papillary carcinomas gave the same survival time in patients, matched for age and sex, who had metastases outside the neck. Those considered to be free of their metastatic disease after I-131 therapy survived three times as long as those with persistent disease. Patients freed of their metastases had a higher conformity rate with half of our ten procedures of "ideal" treatment, compared with patients not freed of their metastases.

摘要

1947年至1980年间,103例颈部以外有转移的高分化甲状腺癌患者在手术治疗后接受了碘化钠(I-131)治疗。41例患者首次发现远处转移,平均在确诊甲状腺癌的初始手术后7.44年。在年龄和性别匹配的颈部以外有转移的患者中,滤泡癌和乳头状癌的生存时间相同。接受I-131治疗后被认为无转移性疾病的患者的存活时间是仍有持续性疾病患者的三倍。与未清除转移灶的患者相比,清除转移灶的患者与我们十种“理想”治疗程序中的一半程序的符合率更高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验